News
NEWS
-
newsCelaid Therapeutics’ CDO Asako Uchiyama to Speak at AABB Annual Meeting and Cord Blood Connect 2026
-
financing
Celaid Therapeutics Completes Second Close of Series B Financing Round
-
newsParticipation in the Cell & Gene Meeting on the Mesa 2026
-
newsCelaid Therapeutics at BioJapan 2026
-
R&DCLD-001 Development Program Passes Second AMED Stage-Gate Review and Advances to Stage 3
-
newsSpeaking at LINK-J FESTIVAL 2026
-
newsSpeaking at TECHNIUM Global Conference 2026
-
newsSpeaking at the 1st KYOTO KLIS-X MEETUP 2026
-
newsOur CEO Nobuyuki Arakawa to Speak at the MEDISO Seminar